Decorin is a small leucine-rich proteoglycan that modulates the activity of TGF-β and other growth factors, and thereby influences the processes of proliferation and differentiation in a wide array of physiological and pathological reactions. Hence, understanding the regulatory mechanisms of decorin activity has broad implications. Here we report that the extracellular levels of decorin are controlled by receptor-mediated catabolism, involving the LDL receptor family member, LRP. We show that decorin is endocytosed and degraded by C2C12 myoblast cells and that both processes are blocked by suppressing LRP expression using siRNA. The same occurs with CHO cells, but not with CHO cells genetically deficient in LRP. Finally, we show that LRP-null CHO cells, transfected to express mini LRP polypeptides containing either the second or fourth LRP ligand-binding domains, carry out decorin endocytosis and lysosomal degradation. These findings point to LRP-mediated catabolism as a new control pathway for the biological activities of decorin, specifically for its ability to influence extracellular matrix signaling.
Decorin is a small leucine-rich proteoglycan that modulates the activity of TGF-β and other growth factors, and thereby influences the processes of proliferation and differentiation in a wide array of physiological and pathological reactions. Hence, understanding the regulatory mechanisms of decorin activity has broad implications. Here we report that the extracellular levels of decorin are controlled by receptor-mediated catabolism, involving the LDL receptor family member, LRP. We show that decorin is endocytosed and degraded by C2C12 myoblast cells and that both processes are blocked by suppressing LRP expression using siRNA. The same occurs with CHO cells, but not with CHO cells genetically deficient in LRP. Finally, we show that LRP-null CHO cells, transfected to express mini LRP polypeptides containing either the second or fourth LRP ligand-binding domains, carry out decorin endocytosis and lysosomal degradation. These findings point to LRP-mediated catabolism as a new control pathway for the biological activities of decorin, specifically for its ability to influence extracellular matrix signaling.
Decorin is one of the most studied members of the family of small leucine-rich proteoglycans. Its core protein, which constitutes up to 80% of the protein moiety, is composed of 12-fold repeats of a 24 amino acid residue (leucine-rich repeats). In addition, decorin carries a single glycosaminoglycan (GAG) chain at its NH2 terminus. A crystal structure for bovine decorin has been published (1) that together with earlier xray scattering data (2) suggests decorin to be a dimeric protein. Each monomer adopts a curved structure, whereby anti-parallel dimerization occurs through the β-sheet on the monomer's concave surface.
Several different functions, based on the interaction of the core protein with other proteins, have been established for decorin, one example being the regulation of extracellular matrix (ECM) assembly. Decorin regulates collagen fibril formation and stabilization, and also modulates cell adhesion (3) . The interaction of decorin with fibronectin and thrombospondin leads to the inhibition of fibroblast attachment to these substrata (4, 5) . In addition to the interaction with ECM constituents, decorin interacts with several growth factors and plasma membrane-located receptors. For instance, it is well known that decorin has the ability to form complexes with transforming growth factor type-β  (TGF-β) (6) , bind to the insulin-like growth factor-I (7) and interact with tumor necrosis factor-alpha (8) . Furthermore, the ectopic expression of decorin has been shown to retard the growth of various tumor cells, an effect that can be attained by exogenously applying recombinant decorin to a wide variety of cells (9) (10) (11) (12) . Decorin is also known to cause rapid phosphorylation of the EGF receptor and concurrent activation of the mitogen-activated protein kinase signaling pathway (13) . Recent studies have shown that decorin binds to the insulin-like growth factor-I receptor, inducing its phosphorylation and activation, followed by receptor down-regulation (7) . On the other hand, reducing decorin levels results in a decreased cell responsiveness to TGF-β, suggesting that decorin is required to activate the TGF-β signaling pathways (14) .
Considering the different ECM-related functions exhibited by decorin, including the accumulation of growth factors and its interaction with matrix constituents, as well as several transducing receptors at the cell surface, it is evident that the regulation of extracellular decorin concentrations, by varying its biosynthesis and degradation rates, is of great physiological importance.
The metabolism of decorin has been studied most intensively in cultured fibroblasts, in which decorin represents the major proteoglycan species and is secreted into the culture medium, where it follows secretion-recapture cycles (15) . Fibroblasts and other cells of mesenchymal origin are known to efficiently internalize decorin by receptor-mediated endocytosis (16, 17) . Several concerted yet unsuccessful efforts have been made to identify the endocytic receptor of decorin. Two proteins of 51 and 26 kDa, present in endosomes and at the plasma membrane, are considered putative decorin receptors (18) . However, no functional evidence is as yet available to support this notion, so that the identity of the decorin receptor remains an open question.
The low density lipoprotein (LDL) receptor-related protein, LRP, is a giant receptor belonging to the LDL receptor family, which binds, endocytoses and mediates the degradation of several ligands (19) . The receptor's folding process in the endoplasmic reticulum requires the participation of the 39-kDa receptor chaperone, RAP (20) . This chaperone protein has also been used as a tool and competitor to study novel ligands for LRP, since recombinant RAP binds with high affinity to the receptor's ligand-binding domains, at the cell surface.
Through its large ectodomain, which contains four ligand-binding domains, LRP binds (among other proteins) multiple ECM molecules, including thrombospondin (21) (22) (23) , fibronectin (24) , plasminogen activators (25, 26) , matrix metalloproteinases (27) and connective tissue growth factor (28) . Furthermore, LRP regulates signaling cascades by binding ECM molecules, such as fibronectin (29) and thrombospondin (30) , and growth factors, such as platelet-derived growth factor (31, 32) , connective tissue growth factor (33) , and TGF-β  (34, 35) . Interestingly, several of these molecules also bind decorin (36) (37) (38) (39) .
Given the role of decorin in myoblast differentiation (14, 40) , and the presence of LRP mRNA in human skeletal muscle cells (41) , in the present study, we tested whether decorin endocytosis in C2C12 mouse myoblasts was affected by the presence of the RAP-inhibitable receptor, LRP. Our results showed unequivocally that in LRP-expressing C2C12 myoblasts, the internalization and degradation of decorin depended on its interaction with this endocytic receptor. Furthermore, we also demonstrated that in Chinese ovary cells (CHO), LRP was also responsible for decorin endocytosis, involving at least the receptor's ligand-binding domains 2 and 4.
EXPERIMENTAL PROCEDURES
Reagents-Plasmids encoding LRP mini-receptors, which include the ligand-binding domains 2 (mLRP2) and 4 (mLRP4) have been described previously (42, 43) . Annealed LRP-1-specific siRNA, as well as control siRNA, were obtained from Ambion, Texas, with LRP siRNA sequences described in (44) . GST and GST-RAP were produced as described in (45) . Rabbit anti-LRP antibody was kindly provided by Dr. Guojun Bu and used as prescribed by Marzolo et al. (42) . Mouse anti-LRP raised against the cytoplasmic domain was purchased from Calbiochem, CA, and mouse anti-α-tubulin from Sigma (Sigma-Aldrich, CO). Adenoviral vector containing the full-length cDNA for human decorin (Adv-Dcn) has already been described (14) . Decorin core protein was obtained from R&D system, MN, full-length decorin and biglycan were purchased from Sigma-(Sigma Aldrich, MO). To determine the amount of chondroitin and dermatan sulphate in the commercial decorin, decorin was radiolabeled with Cell Culture and Transfection-The mouse skeletal muscle cell line C2C12 (ATCC) (46) was grown and induced to differentiate, as described in (47) . The U87 glioblastoma cell line was cultured in MEM with 0.1% nonessential amino acids and 1mM sodium pyruvate. Wild-type Chinese hamster ovary cells (CHO-K1) were cultured in Dulbecco's modification of Eagle's minimal essential medium (DMEM), with 10% fetal bovine serum (FBS), whereas LRP-deficient cells (LRP-null CHO) (48) were cultured in F12 medium with 10% FBS. Clonal cell lines, derived from LRP-null CHO cells expressing LRP mini-receptors, were obtained by transfection, using 2 µg of plasmid DNA and Lipofectamine Plus transfection reagent (Invitrogen, CA) in 35 mm dishes, according to the supplier's protocol. Cells were screened and analyzed by western blot and immunofluorescence. Selected clones were then maintained in wild-type medium containing 0.4 mg/ml G418. 4 (NEN, MA, 25 mCi/ml). This conditioned media was then removed, concentrated and partially purified on a DEAESephacel column, pre-equilibrated in 10 mM TrisHCl, pH 7.4, 0.2 M NaCl and 0.1% Triton X-100. Column-bound samples were incubated with heparitinase, in appropriate buffer for 4 hours at 37°C, in order to degrade any heparan sulfate proteoglycans present in the conditioned medium. The DEAE-Sephacel was incubated with 1M NaCl and the eluate dialyzed against phosphate-buffered saline (PBS). In experiments using decorin core protein, the carrier-free decorin core protein (R&D system, MN) was radiolabeled with Na[ ]-decorin and either recombinant decorin core protein (22 nM), bovine decorin containing GAGs (22 nM), heparin (100 µg/ml), GST (1 µM) or GST-RAP (1 µM). The cells were then sequentially washed in cold KRH-BSA and KRH. For crosslinking assays, cells were incubated with crosslinker agent DSS in KRH buffer for 30 min at 4°C. The reaction was stopped by adding buffer 10 mM Tris-HCl, pH 7.4 containing 250 mM sucrose, (49) . In immunoprecipitation experiments, DSS was omitted. Cells were lysed in 50 mM Tris-HCl, pH 7.4, 0.1 M NaCl, 0.5% Triton X-100, containing a cocktail of protease inhibitors and 1mM PMSF. Equal amounts of protein (80 µg) from pre-cleared extracts were separated by SDS-PAGE in 3-8% gradient gels and gels finally dried and exposed under a Phosphor Imager.
RNA Isolation and RT-PCR-
Confocal Immunofluorescence Microscopy-LRP expression and distribution in C1C12 was analyzed by indirect immunofluorescence and confocal. Cells were grown on glass coverslips. For intracellular protein staining, cells were fixed in 3% paraformaldehyde, permeabilized with 0.05% Triton X-100 (51) and incubated for 1 hour with 1:100 mouse anti-LRP antibody, directed against the cytoplasmic tail of human LRP-1 (Calbiochem, CA). The incubation buffer was 50 mM Tris-HCl, pH 7.7, 0.1 M NaCl, and 2% bovine serum albumin. After buffer removal and several washes with the above buffer, bound antibodies were detected by incubating the cells for 30 min with 1:100 affinity-purified fluorescein isothiocyanateconjugated anti-mouse antibodies (Pierce Biotechnology, IL). After rinsing, the slides were viewed under a Pascal Zeiss laser scanning confocal microscope (LSM-5).
Immunoprecipitation and Immunoblot analyses-
For immunoprecipitation assays, myoblasts were lysed in 50 mM Tris-HCl, pH 7.4, 0.1 M NaCl, 0.5% Triton X-100 buffer, containing a cocktail of protease inhibitors and 1mM PMSF. Equal amounts of protein (150 µg) from pre-cleared extracts were immunoprecipitated over-night at 4°C with 5 µg of rabbit anti-LRP, as previously described (50), followed by incubation for 2 hours at 4°C with 20 µl of protein A-agarose beads (Pierce biotechnology, IL). Equal volumes of immunoprecipitated protein were subjected to SDS-PAGE in 3-8 % gradient gels, which were then dried and exposed to Phosphor Imaging or subjected to LRP immunoblot analysis.
For immunoblot assays, cell extracts were prepared in the same Tris buffer as above, containing protease inhibitors and PMSF. Aliquots were separated by SDS-gel electrophoresis in 3-8% gradient polyacrylamide gels, electrophoretically transferred onto nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany) and probed with either rabbit anti-LRP (1/1000) or mouse anti-α-tubulin (1/5000) antibodies (Sigma Aldrich, MO). All immunoreactions were visualized by enhanced chemiluminescence (Pierce biotechnology, IL).
Decorin endocytosis and degradation assays-The rates of [
35 S]-decorin endocytosis and degradation were determined in myoblast cultures, in the absence of serum, as described (16) . Briefly, cells were grown in 6-well plates until reaching 80% confluence, after which [
35 S]-decorin (200,000 cpm) was added (in a total volume of 1 ml) and left for 3 hours at 37°C in the presence or absence of bovine decorin containing GAGs (100 nM), decorin core (100 nM), biglycan (100 nM), heparin (100 µg/ml), chondroitin sulphate (100 nM) GST (1 µM) or GST-RAP (1 µM). In some experiments, cells were treated with LRP siRNA, prior to adding labeled decorin. Since proteoglycan endocytosis is followed by intralysosomal degradation and the concomitant release of inorganic sulfate into the culture medium, endocytosis of Decorin degradation was calculated as the amount of non-TCA-precipitable radioactivity recovered in the medium after incubation, and cpm readings were then transformed to fmol using iodinated decorin-specific activity.
RESULTS

Decorin and decorin core protein are internalized and degraded by C2C12 myoblasts-It has been
proposed that decorin is endocytosed by several cell types, although the receptor responsible for this process has yet to be identified. In order to investigate this issue, we analyzed the endocytosis of decorin in C2C12 myoblasts. Fig. 1A (Fig. 1A right) . Again, these values are higher than those described for fibroblasts (16) . Moreover, it has been previously demonstrated that [ 35 S]-decorin endocytosis and degradation decrease in the presence of heparin (52) . In order to determine whether these processes were dependent on the GAG chains present in decorin, we repeated the experiments using a decorin core protein devoid of GAGs. Fig. 1B shows that this [ 125 I]-labeled decorin core protein was efficiently degraded in a process that was inhibited by unlabeled decorin core protein, commercial biglycan isolated from cartilage, heparin and also by the lysosomal inhibitor, chloroquine. These results indicate that C2C12 myoblasts were able to internalize and degrade whole decorin molecules, as well as decorin core proteins.
Decorin clearance and degradation are inhibited by RAP-To gain more insight into the possible endocytic receptor(s) involved in the uptake of decorin, C2C12 myoblasts were incubated with [
35 S]-decorin in the presence of GST-RAP, which prevents the association of several ligands to members of the LDL receptor family. Upon coincubation with RAP, both [
35 S]-decorin clearance and degradation were strongly inhibited, while incubating with GST alone had no effect ( Fig. 2A) . ]-decorin core protein continued up to 300 min. Both processes were inhibited by GST-RAP, suggesting that a member of the LDL receptor family could be involved in the process of decorin endocytosis. In order to assign the role of the core protein and the GAGs in the decorin´s internalization and degradation process, inhibited by RAP, we evaluated the role of the core, the GAGs and both together in the up-take and degradation of 35 Sdecorin. Fig. 3 shows that the whole unlabeled decorin molecule inhibited both the clearance and degradation of 35 S-decorin to the same extent than RAP. The core alone, as well as chondroitin sulphate, was less effective in inhibiting the clearance and degradation. Interestingly, when added together the inhibition was similar to the observed using the whole decorin, suggesting that both moieties participate in the interaction with LRP and in its subsequent degradation.
Myoblasts express LRP that interacts with decorin-
We next evaluated whether C2C12 myoblasts expressed LRP, by carrying out RT-PCR assays for LRP using mRNA isolated from C2C12 myoblasts, and from U87 cells as a positive control, given that in these cells, the trafficking and function of LRP have been well characterized (53) . C2C12 myoblasts were seen to express LRP mRNA (Fig. 4A) as well as the protein, after performing western blots (Fig. 4B ). Finally, we tested for the presence of LRP by indirect immunofluorescence using confocal microscope, using a polyclonal antibody against human LRP. As seen in Fig. 4C , C2C12 myoblasts were positive for LRP, with the majority of receptors being intracellular, reflecting a high endocytic activity. These results clearly demonstrated the expression of LRP in C2C12 myoblasts. Interestingly, we also found that LRP protein levels diminished during skeletal muscle differentiation, as seen by western blotting (Fig.  4D) .
To evaluate the possible interaction between decorin and LRP at the molecular level, myoblasts were incubated with [ After separation by SDS-PAGE, autoradiography revealed that decorin coimmunoprecipitated with the LRP-antibody complexes (Fig. 5A ). The same figure shows that this interaction was inhibited by the addition of excess unlabeled decorin core protein, full-length decorin isolated from cartilage and by GST-RAP, while GST alone had no effect. To analyze the direct interaction between decorin core protein and LRP at the cell surface, C2C12 myoblasts were incubated with [ 125 I]-decorin core protein at 4ºC for 3 hours, after which excess labeled decorin was removed, a cross-linker agent (DSS) added, and cell lysates immunoprecipitated against LRP. SDS-PAGE followed by autoradiography (Fig. 5B) showed that decorin core protein interacted with LRP and migrated as a high molecular weight complex. To determine whether RAP was able to affect the formation of this complex, the same crosslinking experiment was carried out in the presence of GST-RAP. As seen in Fig. 5C , GST-RAP inhibited the formation of the high molecular weight complex, in contrast to controls or the incubation of myoblasts with GST alone (seen in Fig. 5A ). Together, these results not only show that myoblasts express LRP, but also that decorin specifically interacts with this receptor.
Specific inhibition of LRP protein synthesis eliminates the interaction, endocytosis and degradation of decorin-
To focus on the functional relationship between decorin and LRP, C2C12 myoblasts were transfected with a specific siRNA for LRP. Fig. 6A shows that LRP expression was strongly inhibited by LRP siRNA, as has been previously reported (44) , whereas transfection with siRNA-Control had no effect on LRP levels in these cells. Under these experimental conditions, the complex previously formed between [ 125 I]-decorin core protein and LRP, did not arise, as indicated in Fig. 6B . Given that these results provided strong evidence for the formation of a decorin-LRP complex, we next investigated whether inhibiting LRP synthesis would have a functional impact on decorin endocytosis and degradation. Fig. 7A shows that strong inhibition of [ 35 S]-decorin clearance occurred in myoblasts transfected with LRP siRNA, in contrast to cells transfected with siRNA-Control. Moreover, the degradation of [ 35 S]-decorin was also strongly inhibited by the lack of LRP expression (Fig. 7B) . These results all point to LRP as the endocytic receptor for decorin in C2C12 myoblasts.
CHO cells rely on LRP expression in order to
degrade decorin core protein-To confirm the results obtained in myoblasts, whereby decorin endocytosis and degradation were inhibited by the absence of endogenous LRP resulting from siRNA techniques, we evaluated the ability of a CHO cell line, devoid of LRP expression, to degrade decorin core protein. Fig. 8A shows that, unlike LRP-null CHO cells, wild type CHO-KI cells were able to degrade [ 125 I]-decorin core protein, and that this process was strongly inhibited by GST-RAP. As a comparison, the values of core protein degradation and inhibition by GST-RAP are shown for C2C12 myoblasts as well. In order to characterize the LRP ligand-binding domains involved in decorin binding, we transfected LRP-null CHO cells with the cDNA encoding for LRP mini-receptors. These contain, at the ectodomains, the second (mLRP2) or the forth (mLRP4) ligand-binding domains of LRP, and all the other receptor regions (namely, the transmembrane and cytoplasmic domains). As reported for other ligands (43), we found that both mini-receptors were able to mediate decorin internalization and degradation in CHO cells (Fig.  8B) . These results unequivocally confirm that LRP is an endocytic receptor for decorin, and that its ability to recognize decorin, involves at least two of its ligand-binding domains.
DISCUSSION
In this paper we show for the first time, that the multiligand receptor LRP functions as the endocytic receptor for decorin. To sustain this fact, we examine the inhibition of decorin endocytosis and degradation by specifically abolishing the expression of LRP using siRNA, and by precluding decorin uptake using RAP, an inhibitor of the interaction between LRP and several ligands (20) . Furthermore, experiments using cells that do not express LRP showed these to be unable to take up and degrade decorin. LRP was also found to interact with decorin through the proteoglycan's core protein. Thus, either the whole proteoglycan molecule or its core protein were specifically endocytosed and degraded, and both processes inhibited by RAP or depletion of LRP using siRNA. We also show that the endocytosis of decorin resulted from a direct interaction between LRP and decorin. Evidence for this was provided by crosslinking assays using radiolabeled decorin and by co-immunoprecipitating LRP with labeled decorin, noting again that both reactions were inhibited by RAP. The interaction between decorin and LRP was deemed specific, as in the presence of exogenous competitors, namely the decorin core protein or the full molecule, the coimmunoprecipitation of LRP and decorin was reduced. The LRP mediated clearance and degradation processes of sulphated decorin, was partially blocked with chondroitin sulphate alone or the core protein of decorin. However, the inhibitory effect of both elements was additive, suggesting that the core and the GAGs moieties have a role in the interaction with LRP.
Experiments measuring the kinetics of decorin internalization and degradation suggested that lysosomes were likely to be involved in these processes, given that the lysosomal inhibitor chloroquine, inhibited the degradation of radiolabeled decorin core protein by approximately 90%. The related proteoglycan biglycan was also able to inhibit decorin degradation, confirming previous findings (54) and suggesting that biglycan could also be endocytosed by LRP. The endocytosis of decorin was first described by Kresse's group (16, 55) , although the receptor required for decorin binding and subsequent endocytosis was not identified. A protein of 51 kDa, present in endosomes and at the plasma membrane, has been suggested to act as the decorin receptor due to its high affinity for the decorin core protein (18, 55, 56) . However, no data has shown this protein to have a functional role in the uptake and degradation of decorin, as it was clearly shown for LRP in this work. Although our results clearly demonstrate that decorin is endocytosed via LRP, and subsequently degraded, a possible role for the 51 kDa protein in these processes cannot be discarded.
On the other hand, decorin's endocytic receptor has also been suggested to contain a binding site for heparin/heparan sulfate, after observing the inhibition of decorin endocytosis in the presence of heparin (52, 57) . Several LRP ligands, such as factor IXa and factor VIII complexed with van Willebrand factor, bind and are also properly presented to the receptor by heparan sulfate proteoglycans (58) . This could also be the case for decorin, since its endocytosis and degradation were inhibited by both RAP and heparin. LRP also binds and endocytoses several ECM molecules, including fibronectin (24), thrombospondin (21) (22) (23) , plasminogen activators (27, 59 ) and matrix metalloproteinases (27) , thereby regulating their bioavailability and functions. These processes involve, in many cases, the activation of signal transduction pathways related to different physiological roles. Thus, LRP participates in events such as cell migration (30, 60) , myofibroblast differentiation (33), growth inhibition (61), lipoprotein catabolism (62), angiogenesis and metastasis (19, 27) , among others. Therefore it is appealing to study the potential role of LRP in modulating bioavailability and consequent signaling of decorin specifically during myogenesis (63) . Here we show that upon differentiation of C2C12 myoblasts, LRP expression decreased, which would have functional implications for several processes, including ECM formation and composition, essential processes that are regulated during differentiation (64) . The regulation of LRP expression is complex and depends on the cellular context. For example, both the over-expression and down-regulation of LRP have been observed in different cancers (65, 66) . In adipocytes, LRP is upregulated by peroxisome proliferator-activated receptor gamma (67) . In PC12 cells, TGF-β2 increases mRNA and protein expression of LRP (68) and in retinal pigment epithelial cells, LRP-1 mRNA expression is strongly increased upon cell stimulation with TGF-β1, TGF-β2, or vascular endothelial growth factor, VEGF, while platelet derived growth factor, PDGF, and fibroblast growth factor type 2, FGF-2, elicited only minor effects (69) . In vascular smooth muscle cells, LDL up-regulates LRP expression (70) and in skeletal muscle, LRP expression is decreased upon insulin treatment (41) . Consequently, it would be interesting to characterize the regulatory elements involved in the decrease of LRP expression reported here during skeletal muscle differentiation.
As already mentioned, decorin is also involved in several cellular processes, such as cell adhesion, migration, proliferation and signaling (for a review, see (71) . Therefore, the synthesis and degradation of decorin and accessory molecules required during such processes must be highly regulated. In skeletal muscle, we have previously shown that decorin synthesis is low in myoblasts, yet increases during skeletal muscle differentiation (51) . This observation is concordant with the requirements of a functional and organized ECM in order for skeletal muscle differentiation to proceed successfully (64, 72) . It is well known that decorin interacts with many ECM constituents, the expression of which is also upregulated during myogenesis, including collagen type I, II and IV (73, 74) and fibronectin (75) , and is present in the correctly organized ECM of skeletal muscle (76, 77) . Moreover, decorin is known to induce growth arrest and retard the growth of a variety of tumor cells (78, 79) . This growth arrest is associated with an induction of p21, a potent inhibitor of cyclin-dependent kinase activity (80) . It has also been suggested that the EGF receptor could be involved, through mobilization of intracellular Ca 2+ , in a possible mechanism by which decorin causes growth suppression (81) . Myoblasts are the source of myogenic cells for the formation of skeletal muscle fibers during muscle development and regeneration (82, 83) . The number of skeletal muscle precursors or satellite cells is generally quite small and an active process of myoblast proliferation precedes the formation and repair of injured muscle (84) . One can therefore speculate that the active clearance of decorin by LRP from the myoblast conditioned medium, described in this paper, could result in a loss of decorin inhibition on myoblast proliferation, during this stage of differentiation. Since LRP protein levels decrease during skeletal muscle differentiation, it is likely that when proliferation ceases, decorin is partially if not totally incorporated into the ECM. Interestingly, decorin also binds TGF-β, a strong inhibitor of muscle formation (85), and we have data suggesting that decorin and biglycan modulate the bio-availability of TGF-β for its transducing receptors, by sequestering TGF-β to the ECM. Indeed, the accumulation of decorin and biglycan at the ECM has a strong inhibitory effect on the binding of TGF-β to its transducing receptors and its subsequent signaling activity (86) .
The binding of growth factors to proteoglycans and the consequent modulation of growth factor activities represent an important conceptual advance in the field. In myoblasts, we have shown that the expression of the plasma membrane-associated proteoglycans syndecan-1 and -3 is not only down-regulated during skeletal muscle differentiation (87,88) but is also critical in order to present FGF-2 to its transducing receptors and thereby modulate myogenesis (47, 88) . We and others have shown that decorin can stimulate TGF-β-dependent signaling in osteoblasts and nondifferentiated myoblasts (14, 40) and it has been suggested that decorin might interact with certain cell surface proteins or receptors, as a means of presenting TGF-β to its transducing receptors. The fact that LRP binds decorin in myoblasts therefore points to this receptor as a possible candidate for the modulation of TGF-β activity by decorin, observed previously (14) . 4 . C2C12 myoblasts express LRP, the levels of which decrease during myogenesis. A, Total RNA was obtained from C2C12 myoblasts and either treated (+RT) or not treated (-RT) with reverse transcriptase. RT-PCR analyses were performed using specific primers aimed at detecting either LRP or GAPDH mRNA. Total RNA from U87 cells was used as a positive control. B, Western blot analyses were performed to determine the protein levels of LRP in C2C12 myoblast extracts. U87 cell extracts were used as positive controls, and tubulin protein levels are shown as loading controls. C, Cells were permeabilized and processed for confocal indirect immunofluorescent staining, using: (a) anti-LRP antibodies and FITCconjugated secondary antibodies, and (b) controls without anti-LRP antibodies. The bar corresponds to 10 µm. D, Western blots for LRP were performed on the cell extracts of myoblasts induced to differentiate for 0, 2, 4 or 6 days. U87 cell extracts were used as positive controls, and for all cells, tubulin protein levels provided a loading control. After crosslinking, cell extracts were electrophoretically separated by SDS-PAGE. Gels were stained, dried, and exposed under a Phosphor Imager to detect radiolabeled proteins (upper panel). Total protein levels are shown by Coomassie Blue staining (lower panel). 
